weight loss injections tirzepatide side effects Chicago Is Tirzepatide Approved in India?

Join over 10 million satisfied users and experience the most modern, personal primary care available

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH

CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027

Retatrutide: Emerging Contender Retatrutide, an innovative tri-agonist compound, is showing promising potential in the arena of health care

With our expert team, convenient location, and personalized care, you can start your journey to a healthier, happier you

Gillette Guyonnet S, Andrieu S, Vellas B